Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients

Recent studies have revealed that the lung microbiota of critically ill patients is altered and predicts clinical outcomes. The incidence of invasive fungal infections, namely, invasive pulmonary aspergillosis (IPA), in immunocompromised patients is increasing, but the clinical significance of variations in lung bacterial communities is unknown.To define the contribution of the lung microbiota to the development and course of IPA.We performed an...